{"id":"W4385973055","doi":"10.1016/j.jtocrr.2023.100562","title":"Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With MET Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Kingston Health Sciences Centre; William Osler Health System; Queen's University; Brampton Civic Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Canadian Institutes of Health Research; EMD Serono; Genentech; Incyte; Canadian Cancer Society Research Institute; Helsinn; BeiGene; Merck KGaA; Princess Margaret Cancer Foundation; Sanofi; GlaxoSmithKline; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Oncology; Toxicity; Targeted therapy; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001108723,0.0001866917,0.0006644565,0.0003649813,0.000167537,0.0003783944,0.0002975781,0.0002264346,0.0005462921],"category_scores_gemma":[0.0007607,0.00007599688,0.0004418159,0.0003466252,0.0003041194,0.0002885209,0.0001805797,0.000384191,0.00005852749],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001780521,"about_ca_system_score_gemma":0.001649882,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006185135,"about_ca_topic_score_gemma":0.02024793,"domain_scores_codex":[0.9996933,0.00008650286,0.00002894091,0.00004444945,0.0001067289,0.00004009542],"domain_scores_gemma":[0.9995311,0.0001470402,0.0001417933,0.00002786025,0.00006966188,0.00008252799],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02472104,0.00124219,0.1221162,0.00103191,0.0007226661,0.0007237817,0.0002672282,0.005374013,0.04040369,0.0006416771,0.001203994,0.8015516],"study_design_scores_gemma":[0.004504909,0.1001759,0.816206,0.0005497845,0.002077411,0.007600819,0.0004613664,0.01263582,0.0359218,0.001463686,0.01832175,0.00008070492],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9578881,0.03846658,0.0008963882,0.0002923147,0.00002347669,0.0001166065,0.0001555419,0.00002127104,0.002139667],"genre_scores_gemma":[0.9930632,0.005433156,0.0008270936,0.00009220804,0.00002139083,0.00003851597,0.0001216768,0.000003396273,0.0003993938],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006185135,"threshold_uncertainty_score":0.01291865,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09678955994710657,"score_gpt":0.459144782226494,"score_spread":0.3623552222793874,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}